No or late VTE | Early VTE | Total | P-value | |||
---|---|---|---|---|---|---|
N | % | N | % | N | ||
Age | ||||||
< 70 | 131 | 87.3 | 19 | 12.7 | 150 | 0.147 |
≥ 70 | 62 | 93.9 | 4 | 3.1 | 66 | |
Sex | ||||||
Male | 121 | 92.4 | 10 | 7.6 | 131 | 0.075 |
Female | 72 | 84.7 | 13 | 15.3 | 85 | |
BSA | ||||||
< 1.8 | 177 | 90.3 | 19 | 9.7 | 196 | 0.155 |
≥ 1.8 | 16 | 80 | 4 | 20 | 20 | |
BMI | ||||||
< 30 kg/m2 | 188 | 89.5 | 22 | 10.5 | 210 | 0.628 |
≥ 30 kg/m2 | 5 | 83.3 | 1 | 16.7 | 6 | |
DM | ||||||
No | 106 | 86.2 | 23 | 17 | 123 | 0.082 |
Yes | 87 | 93.5 | 6 | 6.5 | 93 | |
Site of primary mass | ||||||
Head | 89 | 88.1 | 12 | 11.9 | 101 | 0.261 |
Body | 34 | 97.1 | 1 | 2.9 | 35 | |
Tail | 70 | 87.5 | 10 | 12.5 | 80 | |
Previous surgery | ||||||
Palliative | 11 | 91.7 | 1 | 8.3 | 12 | 0.789 |
None | 182 | 89.2 | 22 | 10.8 | 204 | |
ECOG PS | ||||||
0–1 | 174 | 88.8 | 22 | 11.2 | 196 | 0.390 |
2–3 | 19 | 95 | 1 | 5 | 20 | |
WBC | ||||||
< 11,000/μL | 162 | 89.5 | 19 | 10.5 | 181 | 0.87 |
≥ 11,000/μL | 31 | 88.6 | 4 | 11.4 | 35 | |
Hb | ||||||
< 10 g/dL | 28 | 84.8 | 5 | 15.2 | 33 | 0.276 |
≥ 10 g/dL | 165 | 90.2 | 18 | 9.8 | 183 | |
Platelet | ||||||
< 350,000/μL | 172 | 91.5 | 16 | 8.5 | 188 | 0.008 |
≥ 350,000/μL | 21 | 75 | 7 | 25 | 28 | |
Khorana score | ||||||
Intermediate-risk (2) | 126 | 93.3 | 9 | 6.7 | 135 | 0.014 |
High-risk (≥3) | 67 | 82.7 | 14 | 17.3 | 81 | |
Na | ||||||
< 135 mmol/L | 26 | 76.5 | 8 | 23.5 | 34 | 0.008 |
≥ 135 mmol/L | 167 | 91.8 | 15 | 8.2 | 182 | |
CA19–9 | ||||||
< 1000 U/mL | 105 | 89.7 | 12 | 10.3 | 117 | 0.839 |
≥ 1000 U/mL | 88 | 88.9 | 11 | 11.1 | 99 | |
Number of metastatic organs | ||||||
< 3 | 45 | 95.7 | 2 | 4.3 | 47 | 0.108 |
≥ 3 | 148 | 87.6 | 21 | 12.4 | 169 |